Manmeet Ahluwalia, Baptist Health Medical Group; Miami Cancer InstituteFollow
Recurrent or refractory primary central nervous lymphoma: therapeutic considerations
Additional authors and institutional affiliations
Expert Review of Anticancer Therapy (2013) 13(9):1109-19
This document is currently not available here.
Since January 11, 2022
My Account |